Items where authors include "Lee, C."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abed Abud, A. orcid.org/0000-0002-2788-3822, Abi, B. orcid.org/0000-0001-7036-9645, Acciarri, R. et al. (1361 more authors) (2025) Supernova pointing capabilities of DUNE. Physical Review D, 111 (9). 092006. ISSN 2470-0010

Chelban, V. orcid.org/0000-0002-7797-0756, Pellerin, D., Vijiaratnam, N. orcid.org/0000-0002-9671-0212 et al. (50 more authors) (2025) Intronic FGF14 GAA repeat expansions impact progression and survival in multiple system atrophy. Brain. ISSN 0006-8950

Little, S. orcid.org/0000-0002-9902-0217, Zhou, Y., Heathcote, S. et al. (2 more authors) (2025) We need to talk about racism: co-constructing research with young people from multilingual Chinese backgrounds. Journal of Race, Ethnicity and Politics. ISSN 2056-6085

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Bentham, R., Jones, T.P. orcid.org/0000-0003-2748-0780, Black, J.R.M. orcid.org/0000-0001-5598-7752 et al. (327 more authors) (2025) ImmuneLENS characterizes systemic immune dysregulation in aging and cancer. Nature Genetics, 57. pp. 694-705. ISSN 1061-4036

Biswas, D. orcid.org/0000-0001-9141-5188, Liu, Y.-H. orcid.org/0009-0001-1508-5276, Herrero, J. orcid.org/0000-0001-7313-717X et al. (267 more authors) (2025) Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma. Nature Cancer, 6. pp. 86-101. ISSN 2662-1347

Black, J.R.M. orcid.org/0000-0001-5598-7752, Bartha, G., Abbott, C.W. et al. (277 more authors) (2025) Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma. Nature Medicine, 31 (1). pp. 70-76. ISSN 1078-8956

Puttick, C. orcid.org/0009-0006-3022-8737, Jones, T.P. orcid.org/0000-0003-2748-0780, Leung, M.M. orcid.org/0000-0001-9555-1080 et al. (279 more authors) (2024) MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution. Nature Genetics, 56. pp. 2121-2131. ISSN 1061-4036

Abed Abud, A., Abi, B., Acciarri, R. et al. (1359 more authors) (2024) Performance of a modular ton-scale pixel-readout liquid argon time projection chamber. Instruments, 8 (3). 41. ISSN 2410-390X

Darbyshire, J., Greenhalgh, T., Bakerly, N.D. et al. (34 more authors) (2024) Improving quality in adult long covid services: Findings from the LOCOMOTION quality improvement collaborative. Clinical Medicine, 24 (5). 100237. ISSN 1470-2118

Abed Abud, A., Abi, B., Acciarri, R. et al. (1318 more authors) (2024) Doping liquid argon with xenon in ProtoDUNE single-phase: effects on scintillation light. Journal of Instrumentation, 19. P08005. ISSN 1748-0221

Hobor, S., Al Bakir, M. orcid.org/0000-0002-0846-8332, Hiley, C.T. et al. (292 more authors) (2024) Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling. Nature Communications, 15. 4871. ISSN 2041-1723

Hynds, R.E. orcid.org/0000-0002-2170-8791, Huebner, A. orcid.org/0000-0001-8009-4999, Pearce, D.R. orcid.org/0000-0001-8443-2924 et al. (274 more authors) (2024) Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models. Nature Communications, 15 (1). 4653. ISSN 2041-1723

Sivan, M., Smith, A.B., Osborne, T. et al. (8 more authors) (2024) Long COVID Clinical Severity Types Based on Symptoms and Functional Disability: A Longitudinal Evaluation. Journal of Clinical Medicine, 13 (7). 1908. ISSN 2077-0383

Lee, C., Greenwood, D. C. orcid.org/0000-0001-7035-3096, Master, H. et al. (15 more authors) (2024) Prevalence of orthostatic intolerance in Long Covid clinic patients and healthy volunteers: A multicentre study. Journal of Medical Virology, 96 (3). e29486. ISSN 0146-6615

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Pan, X., AbdulJabbar, K. orcid.org/0000-0002-4411-4435, Coelho-Lima, J. et al. (276 more authors) (2024) The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma. Nature Cancer, 5 (2). pp. 347-363. ISSN 2662-1347

Boutan, C. orcid.org/0000-0002-1470-1946, Carosi, G. orcid.org/0000-0003-0130-6979, Rosenberg, L.J. orcid.org/0000-0003-0686-0485 et al. (23 more authors) (2023) Axions beyond gen 2. International Journal of Modern Physics A, 38 (33 & 34). 2330012. ISSN 0217-751X

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Baxter, S. orcid.org/0000-0002-6034-5495, Barnes, A. orcid.org/0000-0002-8122-9792, Lee, C. et al. (2 more authors) (2023) Increasing public participation and influence in local decision-making to address social determinants of health : a systematic review examining initiatives and theories. Local Government Studies, 49 (5). pp. 861-887. ISSN 0300-3930

Aalbers, J., Akerib, D.S., Akerlof, C.W. et al. (345 more authors) (2023) First dark matter search results from the LUX-ZEPLIN (LZ) experiment. Physical Review Letters, 131. 041002. ISSN 0031-9007

Abud, A.A., Abi, B., Acciarri, R. et al. (1224 more authors) (2023) Reconstruction of interactions in the ProtoDUNE-SP detector with Pandora. The European Physical Journal C, 83. 618.

Abed Abud, A., Abi, B., Acciarri, R. et al. (1315 more authors) (2023) Impact of cross-section uncertainties on supernova neutrino spectral parameter fitting in the Deep Underground Neutrino Experiment. Physical Review D, 107 (11). 112012. ISSN 2470-0010

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Abud, A.A., Abi, B., Acciarri, R. et al. (1256 more authors) (2023) Identification and reconstruction of low-energy electrons in the ProtoDUNE-SP detector. Physical Review D, 107 (9). 092012. ISSN 2470-0010

Abed Abud, A., Abi, B., Acciarri, R. et al. (1303 more authors) (2023) Highly-parallelized simulation of a pixelated LArTPC on a GPU. Journal of Instrumentation, 18 (04). P04034. ISSN 1748-0221

Ng, K.W., Boumelha, J., Enfield, K.S.S. orcid.org/0000-0002-4551-6073 et al. (328 more authors) (2023) Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature, 616. pp. 563-573. ISSN 0028-0836

Martínez-Ruiz, C. orcid.org/0000-0002-4817-0565, Black, J.R.M., Puttick, C. et al. (294 more authors) (2023) Genomic–transcriptomic evolution in lung cancer and metastasis. Nature, 616. pp. 543-552. ISSN 0028-0836

Abbosh, C. orcid.org/0000-0002-8983-1382, Frankell, A.M. orcid.org/0000-0002-0341-7878, Harrison, T. et al. (303 more authors) (2023) Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature, 616 (7957). pp. 553-562. ISSN 0028-0836

Frankell, A.M. orcid.org/0000-0002-0341-7878, Dietzen, M. orcid.org/0000-0002-6853-7563, Al Bakir, M. orcid.org/0000-0002-0846-8332 et al. (284 more authors) (2023) The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature, 616. pp. 525-533. ISSN 0028-0836

Al Bakir, M. orcid.org/0000-0002-0846-8332, Huebner, A. orcid.org/0000-0001-8009-4999, Martínez-Ruiz, C. orcid.org/0000-0002-4817-0565 et al. (283 more authors) (2023) The evolution of non-small cell lung cancer metastases in TRACERx. Nature, 616. pp. 534-542. ISSN 0028-0836

Hill, W., Lim, E.L., Weeden, C.E. et al. (323 more authors) (2023) Lung adenocarcinoma promotion by air pollutants. Nature, 616 (7955). pp. 159-167. ISSN 0028-0836

Al-Sawaf, O. orcid.org/0000-0001-9895-0570, Weiss, J., Skrzypski, M. et al. (302 more authors) (2023) Body composition and lung cancer-associated cachexia in TRACERx. Nature Medicine, 29 (4). pp. 846-858. ISSN 1078-8956

Karasaki, T. orcid.org/0000-0001-6863-2360, Moore, D.A. orcid.org/0000-0002-6296-1312, Veeriah, S. et al. (288 more authors) (2023) Evolutionary characterization of lung adenocarcinoma morphology in TRACERx. Nature Medicine, 29 (4). pp. 833-845. ISSN 1078-8956

Feng, J.L. orcid.org/0000-0002-7713-2138, Kling, F. orcid.org/0000-0002-3100-6144, Reno, M.H. orcid.org/0000-0001-6264-3990 et al. (396 more authors) (2023) The forward physics facility at the high-luminosity LHC. Journal of Physics G: Nuclear and Particle Physics, 50 (3). 030501. ISSN 0954-3899

Bergamino, M.A. orcid.org/0000-0002-1091-2711, López-Knowles, E. orcid.org/0000-0002-0893-3361, Morani, G. orcid.org/0000-0002-6385-3137 et al. (173 more authors) (2022) HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer. eBioMedicine, 83. 104205. ISSN 2352-3964

Wu, Y. orcid.org/0000-0003-4080-3935, Biswas, D. orcid.org/0000-0001-9141-5188, Usaite, I. et al. (302 more authors) (2022) A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nature Cancer, 3. pp. 696-709. ISSN 2662-1347

Lee, C., Parker, G., Buckner, S. et al. (5 more authors) (2022) Neighbourhood planning, rural ageing and public health policy in England : a case of policy myopia? Town Planning Review, 93 (3). pp. 275-300. ISSN 0041-0020

Fenstermacher, M. E., Abbate, J., Abe, S. et al. (827 more authors) (2022) DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy. Nuclear Fusion. 042024. ISSN 1741-4326

Fenstermacher, M. E., Abbate, J., Abe, S. et al. (827 more authors) (2022) DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy. Nuclear Fusion. 042024. ISSN 1741-4326

Fenstermacher, M. E., Abbate, J., Abe, S. et al. (827 more authors) (2022) DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy. Nuclear Fusion. 042024. ISSN 1741-4326

Lee, C. orcid.org/0000-0002-7557-7010, Bailey, C. orcid.org/0000-0003-1969-5001, Burnett, C. orcid.org/0000-0001-6087-244X et al. (1 more author) (2022) Methodological imperatives and perplexities for literacy research in uncertain times. International Studies in Sociology of Education, 31 (1-2). pp. 1-4. ISSN 0962-0214

Fukushima, C.S., Tricorache, P., Toomes, A. et al. (18 more authors) (2021) Challenges and perspectives on tackling illegal or unsustainable wildlife trade. Biological Conservation, 263. 109342. ISSN 0006-3207

Robinson, S.D. orcid.org/0000-0003-0623-4636, Tahir, B.A. orcid.org/0000-0003-0531-3519, Absalom, K.A.R. et al. (6 more authors) (2020) Radical accelerated radiotherapy for non-small cell lung cancer (NSCLC): a 5-year retrospective review of two dose fractionation schedules. Radiotherapy and Oncology, 143. pp. 37-43. ISSN 0167-8140

Rampling, T., Ewer, K.J., Bowyer, G. et al. (32 more authors) (2018) Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP. npj Vaccines, 3 (1). 49. ISSN 2059-0105

Mulvenna, P., Nankivell, M., Barton, R. et al. (16 more authors) (2016) Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. The Lancet, 388 (10055). pp. 2004-2014. ISSN 0140-6736

Proceedings Paper

Hatton, M. orcid.org/0000-0003-2778-7926, Mok, W.K., Das, T. et al. (7 more authors) (2025) 179 Inoperable stage 1 and stage 2 non-small cell lung cancer (NSCLC) treated with COVID-era 15 fraction hypo-fractionated radiotherapy: a single-centre retrospective analysis. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 03-05 Mar 2025, Belfast, Northern Ireland. Elsevier BV , p. 108288.

Corkhill, A., Woolf, D., Hatton, M. orcid.org/0000-0003-2778-7926 et al. (15 more authors) (2025) 252 ThOracic Umbrella RadIotherapy STudy in stage IV NSCLC: TOURIST. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 03-05 Mar 2025, Belfast, Northern Ireland. Elsevier BV , p. 108361.

Hill, K., Woolf, D., Downs, N. et al. (16 more authors) (2025) 253 Prospective, randomised, multicentre trial of first line systemic treatment and radiotherapy in stage IV non-small cell lung cancer: PRINCE a candidate-specific trial within the TOURIST Platform. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 03-05 Mar 2025, Belfast, Northern Ireland. Elsevier BV , p. 108362.

Downs, N., Sutton, C., Corkhill, A. et al. (16 more authors) (2025) 254 Quality of life after radiotherapy treatment for patients with stage IV non-small cell Lung cancer: QUARTZ LUNG a candidate-specific trial within the TOURIST platform. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 2025-03-03 2025-03-05, Belfast, Northern Ireland. Elsevier BV , p. 108363.

Woolf, D., Downs, N., Sutton, C. et al. (15 more authors) (2024) 209 ThOracic Umbrella RadIotherapy STudy in stage IV NSCLC: TOURIST. In: Lung Cancer. 22nd Annual British Thoracic Oncology Group Conference 2024, 17-19 Apr 2024, Belfast, Northern Ireland. Elsevier BV .

Meehan, D., Pang, Y., Fisher, P. et al. (8 more authors) (2023) 85 - Outcomes of patients in South Yorkshire with PDL-1 positive or negative locally advanced or metastatic squamous (NSCLC) treated with first line pembrolizumab in combination with carboplatin and paclitaxel. In: Lung Cancer. 21st Annual British Thoracic Oncology Group Conference 2023, 26-28 Apr 2023, Belfast, Northern Ireland. Elsevier , S37-S37.

Pang, Y.L.P., Meehan, D., Fisher, P. et al. (8 more authors) (2023) 86 - Analyses of real-world data on patient outcomes in South Yorkshire, for patients with metastatic non-squamous lung cancer treated with pembrolizumab plus pemetrexed-platinum-based chemotherapy. In: Lung Cancer. 21st Annual British Thoracic Oncology Group Conference 2023, 26-28 Apr 2023, Belfast, Northern Ireland. Elsevier , S37-S38.

Calman, L., Hancock, A., Lee, C. et al. (15 more authors) (2023) Embedding qualitative research in lung cancer trials: thoracic umbrella radiotherapy study in stage IV NSCLC: TOURIST. In: Lung Cancer. 21st Annual British Thoracic Oncology Group Conference 2023, 26-28 Apr 2023, Belfast, Northern Ireland. Elsevier .

Eardley, J., Pang, Y.L., White, L. et al. (10 more authors) (2023) Retrospective review of patients receiving thoracic palliative radiotherapy (TRT) for non-small-cell lung cancer (NSCLC) in Weston Park Cancer Centre (WPCC): a real world regional cancer centre experience. In: Lung Cancer. 21st Annual British Thoracic Oncology Group Conference 2023, 26-28 Apr 2023, Belfast, Northern Ireland. , S61-S62.

Burney, R., Narayanaswamy, V., Bates, E. et al. (7 more authors) (2023) Two years on: progression free survival analysis of patients with advanced small cell lung cancer receiving atezolizumab plus etoposide and carboplatin in a tertiary oncology centre. In: Lung Cancer. 21st Annual British Thoracic Oncology, 26-28 Apr 2023, Belfast, Northern Ireland. Elsevier .

Ryan, A., Bates, E., Danson, S. orcid.org/0000-0002-3593-2890 et al. (7 more authors) (2020) Outcomes of patients in South Yorkshire with advanced non-small-cell lung cancer treated with second-line atezolizumab following induction with chemotherapy. In: Lung Cancer. 18th Annual British Thoracic Oncology Group Conference 2020, 29-31 Jan 2020, Dublin, Ireland. .

Robinson, S., Tahir, B. orcid.org/0000-0003-0531-3519, Absalom, K. et al. (6 more authors) (2018) P1.17-05 Accelerated radiotherapy for non-small cell lung cancer: a 12 year retrospective review of two dose fractionation schedules. In: Journal of Thoracic Oncology. IASLC 19th World Conference on Lung Cancer, 07-10 Sep 2019, Barcelona, Spain. Elsevier BV , S656-S656.

Hatton, M., Robinson, S., Bradshaw, J. et al. (7 more authors) (2018) Impact of cardiac doses on survival of non-small cell lung cancer (NSCLC) patients following radical accelerated radiotherapy. In: Journal of Thoracic Oncology. European Lung Cancer Congress (ELCC), 11-14 Apr 2018, Geneva, Switzerland. Abstract Book: European Lung Cancer Congress (ELCC), 13 (4). Elsevier , S61-S61.

Garikipati, S., Prakash, A., Alhilali, M. et al. (8 more authors) (2018) Management and outcomes of patients with small cell lung cancer in North Trent. In: Lung Cancer. The 16th Annual British Thoracic Oncology Group Conference 2018, 24-26 Jan 2018, Dublin . Elsevier , S73-S73.

Low, L., Salawu, A., Bates, E. et al. (7 more authors) (2018) The North Trent experience of administering pembrolizumab to previously treated patients with advanced non-small cell lung cancer. In: Lung Cancer. 16th Annual British Thoracic Oncology Group Conference 2018, 24-26 Jan 2018, Dublin, Ireland. Elsevier , S35-S35.

Robinson, S.D., Absalom, K.A., Das, T. et al. (4 more authors) (2018) Post-operative radiotherapy (PORT) for incompletely resected non-small cell lung cancer (NSCLC): single centre audit of outcomes. In: Lung Cancer. The 16th Annual British Thoracic Oncology Group Conference 2018, 24-26 Jan 2018, Dublin . Elsevier , S66-S67.

Robinson, S.D., Absalom, K.A., Lankathilake, A. et al. (5 more authors) (2018) Radical radiotherapy for non-small cell lung cancer (NSCLC): real world outcomes for two accelerated fractionation schedules. In: Lung Cancer. The 16th Annual BTOG, 24-26 Jan 2018, Dublin. Elsevier , S71-S71.

Preprint

Lee, C., Greenwood, D.C. orcid.org/0000-0001-7035-3096, Master, H. et al. (13 more authors) (2023) Prevalence of orthostatic intolerance in Long Covid clinic patients: A multicentre observational study. [Preprint]

Sivan, M., Smith, A.B., Osborne, T. et al. (8 more authors) (2023) Long Covid Clinical Severity Types Based on Symptoms and Functional Disability: A Longitudinal Evaluation. [Preprint]